Onconova Therapeutics Volatility
| ONTXDelisted Stock | USD 7.93 0.00 0.00% |
Onconova Therapeutics is out of control given 3 months investment horizon. Onconova Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-four different technical indicators, which can help you to evaluate if expected returns of 14.18% are justified by taking the suggested risk. Use Onconova Therapeutics Coefficient Of Variation of 774.09, semi deviation of 0.9552, and Risk Adjusted Performance of 0.0898 to evaluate company specific risk that cannot be diversified away. Key indicators related to Onconova Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Onconova Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Onconova daily returns, and it is calculated using variance and standard deviation. We also use Onconova's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Onconova Therapeutics volatility.
Onconova |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Onconova Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Onconova Therapeutics at lower prices. For example, an investor can purchase Onconova stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Onconova Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Onconova Stock
Onconova Therapeutics Market Sensitivity And Downside Risk
Onconova Therapeutics' beta coefficient measures the volatility of Onconova stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Onconova stock's returns against your selected market. In other words, Onconova Therapeutics's beta of -3.33 provides an investor with an approximation of how much risk Onconova Therapeutics stock can potentially add to one of your existing portfolios. Onconova Therapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Onconova Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Onconova Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Onconova Therapeutics Demand TrendCheck current 90 days Onconova Therapeutics correlation with market (NYSE Composite)Onconova Beta |
Onconova standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 96.63 |
It is essential to understand the difference between upside risk (as represented by Onconova Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Onconova Therapeutics' daily returns or price. Since the actual investment returns on holding a position in onconova stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Onconova Therapeutics.
Onconova Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Onconova Therapeutics delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Onconova Therapeutics' price changes. Investors will then calculate the volatility of Onconova Therapeutics' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Onconova Therapeutics' volatility:
Historical Volatility
This type of delisted stock volatility measures Onconova Therapeutics' fluctuations based on previous trends. It's commonly used to predict Onconova Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Onconova Therapeutics' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Onconova Therapeutics' to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Onconova Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days Onconova Therapeutics has a beta of -3.329 . This indicates as returns on its benchmark rise, returns on holding Onconova Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Onconova Therapeutics is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Onconova Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Onconova Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Onconova delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Onconova Therapeutics has an alpha of 11.2717, implying that it can generate a 11.27 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives an Onconova Therapeutics Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Onconova Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Onconova Therapeutics is 681.2. The daily returns are distributed with a variance of 9336.76 and standard deviation of 96.63. The mean deviation of Onconova Therapeutics is currently at 26.26. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α | Alpha over NYSE Composite | 11.27 | |
β | Beta against NYSE Composite | -3.33 | |
σ | Overall volatility | 96.63 | |
Ir | Information ratio | 0.13 |
Onconova Therapeutics Stock Return Volatility
Onconova Therapeutics historical daily return volatility represents how much of Onconova Therapeutics delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 96.6269% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6214% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Onconova Therapeutics Volatility
Volatility is a rate at which the price of Onconova Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Onconova Therapeutics may increase or decrease. In other words, similar to Onconova's beta indicator, it measures the risk of Onconova Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Onconova Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Onconova Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Onconova Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Onconova Therapeutics' price varies over time.
3 ways to utilize Onconova Therapeutics' volatility to invest better
Higher Onconova Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Onconova Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Onconova Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Onconova Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Onconova Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Onconova Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Onconova Therapeutics Investment Opportunity
Onconova Therapeutics has a volatility of 96.63 and is 155.85 times more volatile than NYSE Composite. 96 percent of all equities and portfolios are less risky than Onconova Therapeutics. You can use Onconova Therapeutics to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Onconova Therapeutics to be traded at $7.85 in 90 days.Good diversification
The correlation between Onconova Therapeutics and NYA is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Onconova Therapeutics Additional Risk Indicators
The analysis of Onconova Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Onconova Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Onconova Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0898 | |||
| Market Risk Adjusted Performance | (3.32) | |||
| Mean Deviation | 20.84 | |||
| Semi Deviation | 0.9552 | |||
| Downside Deviation | 3.68 | |||
| Coefficient Of Variation | 774.09 | |||
| Standard Deviation | 85.82 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Onconova Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Onconova Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Onconova Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Onconova Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Onconova Therapeutics.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |